Sec. 204. Medication-assisted treatment
531 words·~2 min read·
/bill/117/hr/2366/ih/section-204A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
In this subsection, the term opioid treatment program means a program or practitioner engaged in opioid treatment of individuals with an opioid agonist treatment medication registered under section 303(g)(1) of the Controlled Substances Act ( 21 U.S.C. 823(g)(1) ). The Secretary shall amend section 8.12(e)(1) of title 42, Code of Federal Regulations (and such other regulations in part 8 of such title 42 as may be necessary) to eliminate the requirement that the person became addicted at least 1 year before admission for maintenance treatment under an opioid treatment program.
Not later than one year after the date of enactment of this Act, the Assistant Secretary shall— complete a survey of the use in opioid treatment programs of take-home prescription medications; and submit a report to Congress on the findings of the survey. The survey under paragraph
(1)shall assess— the frequency of use of take-home medication, as allowed under section 8.12(i) of title 42, Code of Federal Regulations; the extent to which the limitations on doses for take-home use listed in section 8.12(i)(3)(i), (ii), (iii), and
(iv)of such title 42 unduly burden treatment of individuals with opioid use disorder; and whether and how individuals receiving medications for take-home use receive all services listed in section 8.12(f) of such title 42. Not later than 1 year after the date of enactment of this Act, the Assistant Secretary shall complete a study and submit a report to the Congress on ways in which the Substance Abuse and Mental Health Services Administration can provide and support health services, including treatment for substance use disorders, to individuals in rural (including agricultural) and medically underserved communities (as defined in section 799B of the Public Health Service Act ( 42 U.S.C. 295p )), taking into account the following: Stigma. Using data. Telemedicine. Managing fiscal resources in a community impacted by addiction. Workforce development. Broadband. Overcoming economic challenges. Prevention. Transportation. Nutritional services. Medication-assisted treatment. Educating law enforcement personnel about addiction. Drug courts. Educating the faith community about addiction. Recovery support. Housing. Harm reduction services. The Director of the Bureau of Prisons shall establish a program to offer— medication-assisted treatment for opioid use disorder to individuals in the custody of the Bureau of Prisons and include in such treatment all drugs that are approved by the Food and Drug Administration to treat opioid use disorder; and withdrawal management services to individuals in the custody of the Bureau of Prisons to provide a comprehensive treatment approach substance use disorders. To carry out this subsection, there is authorized to be appropriated to the Director of the Bureau of Prisons $150,000,000 for each of fiscal years 2022 through 2026. Section 1904(d) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 ( 34 U.S.C. 10424(d) ) is amended— by striking means and inserting the following: means ; by striking the period at the end and inserting ; and ; and by adding at the end the following: includes any such course of comprehensive individual and group substance abuse treatment services using medication-assisted treatment for opioid use disorder (including the use of any drug approved or licensed by the Food and Drug Administration for such treatment). .
Connectionstraces to 3
Traces to 3 documents
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources